5.26
-0.195(-3.57%)
Currency In USD
| Previous Close | 5.46 |
| Open | 5.38 |
| Day High | 5.45 |
| Day Low | 5.15 |
| 52-Week High | 11.5 |
| 52-Week Low | 5.15 |
| Volume | 3.23M |
| Average Volume | 2.44M |
| Market Cap | 405.09M |
| PE | -3.93 |
| EPS | -1.34 |
| Moving Average 50 Days | 6.62 |
| Moving Average 200 Days | 7 |
| Change | -0.2 |
If you invested $1000 in Altimmune, Inc. (ALT) since IPO date, it would be worth $39.49 as of March 12, 2025 at a share price of $5.26. Whereas If you bought $1000 worth of Altimmune, Inc. (ALT) shares 5 years ago, it would be worth $1,593.94 as of March 12, 2025 at a share price of $5.26.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Altimmune to Host Virtual R&D Day on March 13, 2025
GlobeNewswire Inc.
Mar 06, 2025 12:30 PM GMT
Program to Feature Presentations from Renowned KOLs in Obesity, MASH and Two Additional Indications for Pemvidutide following recent IND Clearances by FDAGAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late c
Altimmune to Participate in the Leerink Global Healthcare Conference
GlobeNewswire Inc.
Mar 03, 2025 12:30 PM GMT
GAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Leerink G
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
GlobeNewswire Inc.
Feb 25, 2025 12:30 PM GMT
Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career Mr. Durso led biopharmaceutical company